½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1555617

¼¼°èÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)

Membrane Oxygenators Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå¿¡ ´ëÇÑ »ó¼¼ÇÑ Á¶»ç¸¦ ¹ßÇ¥ÇÏ¿© ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ºÐ¼®À» Á¦°øÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ±¸Á¶¿Í ¹Ì·¡ ±Ëµµ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ±Ô¸ð(2024³â) : 1¾ï 4,210¸¸ ´Þ·¯
  • ½ÃÀå ¿¹Ãø ±Ý¾×(2033³â) : 1¾ï 6,600¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2033³â CAGR) : 2.0%

¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå : Á¶»ç ¹üÀ§

¸·Çü »ê¼Ò°ø±Þ±â´Â È£Èí ºÎÀü ȯÀÚÀÇ °¡½º ±³È¯À» ÃËÁøÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ÁßȯÀÚ Ä¡·á ¹× ½ÉÀå ¼ö¼ú¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ü¿Ü»ý¸íÀ¯ÁöÀåÄ¡(ECLS) ¹× ü¿Ü¸·»ê¼ÒÈ­ÀåÄ¡(ECMO) ½Ã½ºÅÛ¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇϸç ÀÇ·á ȯ°æ¿¡¼­ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº È£Èí±â ¹× ½ÉÀå ÁúȯÀÇ ¹ßº´·ü Áõ°¡, ECMO ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ´Ù¾çÇÑ Áö¿ªÀÇ ÀÇ·á ÀÎÇÁ¶ó ¹ßÀüÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

¼¼°è ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ È°¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â °í±Þ »ê¼Ò °ø±Þ ½Ã½ºÅÛÀ» »ç¿ëÇØ¾ß ÇÏ´Â ¸¸¼º È£Èí±â ¹× ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ ECMO°¡ »ý¸íÀ» ±¸Çϱâ À§ÇÑ ÁßÀç·Î¼­ Á¡Á¡ ´õ ¸¹ÀÌ ¹Þ¾Æµé¿©Áö°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ¸·Çü »ê¼Ò°ø±Þ±â ¼³°èÀÇ ±â¼úÀû Áøº¸¿Í ½Å»ý¾Æ ¹× ¼Ò¾Æ ÀÇ·á ºÐ¾ß¿¡¼­ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå È®´ë°¡ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í, ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀåÀº ƯÁ¤ °úÁ¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­´Â ECMO ½Ã¼ú ¹× Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ º¸±Þ¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÌ º¹ÀâÇÏ°í ÀÛµ¿À» À§ÇØ Àü¹® ÀÇ·áÁøÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡µµ ½ÃÀå ÁøÀÔ À庮À¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù. ƯÁ¤ Áö¿ª¿¡¼­´Â ECMO¿Í ±× Àû¿ë¿¡ ´ëÇÑ ÀνÄÀÌ ³·´Ù´Â Á¡µµ ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.

½ÃÀå ±âȸ :

¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀåÀº Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ¿¡Å©¸ð ½Ã½ºÅÛÀÇ »ç¿ë È®´ë·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ ¸ÂÀÌÇÏ°í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ¹× »ç¿ëÀÚ Ä£È­ÀûÀÎ »ê¼Ò°ø±Þ±âÀÇ °³¹ß·Î ÀÎÇØ ÀÀ±Þ ¹× ÀçÅÃÄ¡·á ÇöÀå¿¡¼­ ÀÌ·¯ÇÑ ÀåÄ¡¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ °í±Þ ÀÇ·á °³ÀÔÀ» ÅëÇÑ È¯ÀÚ °á°ú °³¼±¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ßÀüÇÏ°í ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­ ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±æÀ» ¿­°Ô µÉ °ÍÀÔ´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®µé

  • ¼¼°è ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¸·Çü »ê¼Ò°ø±Þ±â¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡Àå ³ôÀº Áö¿ªÀº?
  • ±â¼ú ¹ßÀüÀº ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?
  • ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ´©±¸À̸ç, ½ÃÀå ÁöÀ§¸¦ À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇÏ°í Àִ°¡?
  • ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§/ºÐ·ù
  • ½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ

Á¦3Àå ½ÃÀå ¹è°æ

  • ½ÃÀå ¿ªÇÐ
  • ½Ã³ª¸®¿À ¿¹Ãø
  • ±ÔÁ¦ »óȲ

Á¦4Àå ¼¼°èÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼®

  • °ú°Å ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ¿¹Ãø, 2024-2032³â
    • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
    • Àý´ëÀû ¸ÅÃâ ±âȸ

Á¦5Àå ¼¼°èÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®, Á¦Ç° À¯Çüº°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç° À¯Çüº°, 2024-2032³â
    • Hollow Fiber Membrane Oxygenators
    • Flat Sheet Membrane Oxygenators
  • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®, Á¦Ç° À¯Çüº°, 2019-2023³â
  • Àý´ëÀû ¸ÅÃâ ±âȸ, Á¦Ç° À¯Çüº°, 2024-2032³â

Á¦6Àå ¼¼°èÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®, ¿¬·ÉÃþº°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿¬·ÉÃþº°, 2024-2032³â
    • ½Å»ý¾Æ
    • ¼Ò¾Æ
    • ¼ºÀÎ
  • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®, ¿¬·ÉÃþº°, 2019-2023³â
  • Àý´ëÀû ¸ÅÃâ ±âȸ, ¿¬·ÉÃþº°, 2024-2032³â

Á¦7Àå ¼¼°èÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®, ¿ëµµº°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2032³â
    • È£Èí±â
      • È£Èí ºÎÀü
      • Æó»öÀüÁõ
      • ±Þ¼º È£ÈíÃ˹ÚÁõÈıº
      • Æó·Å
      • COVID-19
    • ½ÉÀå
      • ±Þ¼º ½É±Ù°æ»ö
      • ½É±Ù¿°
      • ÀÌ½Ä ÈÄ ÇÕº´Áõ
      • ºñ´ë»ó¼º ½É±ÙÁõ
      • ½É¿ø¼º ¼îÅ©
    • ECPR
  • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®, ¿ëµµº°, 2019-2023³â
  • Àý´ëÀû ¸ÅÃâ ±âȸ, ¿ëµµº°, 2024-2032³â

Á¦8Àå ¼¼°èÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®, Áö¿ªº°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð ±Ý¾×(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2024-2032³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ
    • ¿À¼¼¾Æ´Ï¾Æ
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦9Àå ºÏ¹ÌÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦10Àå ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦11Àå À¯·´ÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦12Àå µ¿¾Æ½Ã¾ÆÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦13Àå ³²¾Æ½Ã¾ÆÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦14Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦15Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦16Àå ÁÖ¿ä ±¹°¡ ¸·Çü »ê¼Ò°ø±Þ±â ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîƼ³ª
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • º£³×·è½º
  • Áß±¹
  • ÀϺ»
  • Çѱ¹
  • Àεµ
  • ű¹
  • ¸»·¹À̽þÆ
  • Àεµ³×½Ã¾Æ
  • È£ÁÖ
  • ´ºÁú·£µå
  • GCC ±¹°¡

Á¦17Àå ½ÃÀå ±¸Á¶ ºÐ¼®

  • °æÀï ´ë½Ãº¸µå
  • °æÀï º¥Ä¡¸¶Å·
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®

Á¦18Àå °æÀï ºÐ¼®

  • °æÀï »ó¼¼
    • MicroPort Scientific Corporation
    • Nipro Medical Corporation
    • Medtronic
    • Fresenius SE &Co KGaA
    • Terumo Medical Corporation
    • Getinge AB

Á¦19Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú µÎÀÚ¾î

Á¦20Àå Á¶»ç ¹æ¹ý

LSH 24.10.18

Persistence Market Research has recently published a detailed report on the global Membrane Oxygenators Market, offering an extensive analysis of key market dynamics, including drivers, trends, opportunities, and challenges. The report presents in-depth insights into the structure of the market and its future trajectory.

Key Insights:

  • Membrane Oxygenators Market Size (2024E): USD 142.1 Mn
  • Projected Market Value (2033F): USD 166 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 2.0%

Membrane Oxygenators Market - Report Scope:

Membrane oxygenators are increasingly being used in critical care and cardiac surgeries due to their ability to facilitate gas exchange for patients with respiratory failure. These devices play a vital role in extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO) systems, making them indispensable in healthcare settings. The market is primarily driven by the rising incidence of respiratory and cardiac disorders, the growing demand for ECMO procedures, and advancements in healthcare infrastructure across various regions.

Market Growth Drivers:

The global membrane oxygenators market is fueled by several important factors. These include the increasing prevalence of chronic respiratory and cardiovascular diseases, which necessitate the use of advanced oxygenation systems. Additionally, the growing acceptance of ECMO as a lifesaving intervention in critical care settings is a major contributor to market growth. Technological advancements in membrane oxygenator design and the rising adoption of these systems in neonatal and pediatric care further support market expansion.

Market Restraints:

Despite its promising growth prospects, the membrane oxygenators market faces certain challenges. High costs associated with ECMO procedures and devices can hinder their widespread adoption, particularly in developing countries. Furthermore, the complexity of these systems and the need for specialized healthcare professionals to operate them add to the barriers to market entry. Limited awareness about ECMO and its applications in certain regions also restricts market growth.

Market Opportunities:

The membrane oxygenators market presents significant growth opportunities driven by ongoing technological innovations and the expanding use of ECMO systems across various healthcare settings. The development of portable and user-friendly oxygenators is expected to increase the accessibility of these devices in emergency and home care settings. Moreover, the rising focus on improving patient outcomes through advanced medical interventions opens up new avenues for market growth, particularly in emerging markets where healthcare infrastructure is evolving.

Key Questions Answered in the Report:

  • What are the main factors driving the global membrane oxygenators market?
  • Which regions are witnessing the highest demand for membrane oxygenators?
  • How are technological advancements impacting the membrane oxygenators market?
  • Who are the leading players in the membrane oxygenators market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the membrane oxygenators market?

Competitive Intelligence and Business Strategy:

Leading players in the global membrane oxygenators market, such as Medtronic, Terumo Cardiovascular Systems, and Getinge AB, are focusing on innovation, product development, and strategic partnerships to stay competitive. These companies are investing in research and development to enhance device efficiency, improve patient outcomes, and expand their product portfolios. Collaborations with healthcare institutions and the introduction of cost-effective solutions for critical care are key strategies driving market growth. Additionally, meeting stringent regulatory requirements and maintaining high product quality remain priorities for companies in this space, ensuring sustained growth in the global membrane oxygenators market.

Key Companies Profiled:

  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Medtronic
  • Fresenius SE & Co KGaA
  • Terumo Medical Corporation
  • Getinge AB

Market Segments Covered in Membrane Oxygenators Market Analysis

By Type

  • Hollow Fiber Membrane Oxygenators
  • Flat Sheet Membrane Oxygenators

By Age Group

  • Neonates
  • Pediatrics
  • Adults

By Application

  • Respiratory
  • Cardiac
  • ECPR

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa(MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Regulatory Landscape
    • 3.3.1. By Key Regions
    • 3.3.2. By Key Countries

4. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2024-2032
    • 5.3.1. Hollow Fiber Membrane Oxygenators
    • 5.3.2. Flat Sheet Membrane Oxygenators
  • 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

6. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Age Group

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Age Group, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Age Group, 2024-2032
    • 6.3.1. Neonates
    • 6.3.2. Pediatrics
    • 6.3.3. Adults
  • 6.4. Y-o-Y Growth Trend Analysis By Age Group, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Age Group, 2024-2032

7. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 7.3.1. Respiratory
      • 7.3.1.1. Respiratory failure
      • 7.3.1.2. Pulmonary embolism
      • 7.3.1.3. Acute respiratory distress syndrome
      • 7.3.1.4. Pneumonia
      • 7.3.1.5. COVID-19
    • 7.3.2. Cardiac
      • 7.3.2.1. Acute myocardial infarction
      • 7.3.2.2. Myocarditis
      • 7.3.2.3. Post-transplant complications
      • 7.3.2.4. Decompensated cardiomyopathy
      • 7.3.2.5. Cardiogenic shock
    • 7.3.3. ECPR
  • 7.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application, 2024-2032

8. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. East Asia
    • 8.3.5. South Asia
    • 8.3.6. Oceania
    • 8.3.7. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Product Type
    • 9.2.3. By Age Group
    • 9.2.4. By Application
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Age Group
    • 9.3.4. By Application
  • 9.4. Key Takeaways

10. Latin America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Argentina
      • 10.2.1.4. Rest of Latin America
    • 10.2.2. By Product Type
    • 10.2.3. By Age Group
    • 10.2.4. By Application
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Age Group
    • 10.3.4. By Application
  • 10.4. Key Takeaways

11. Europe Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. Italy
      • 11.2.1.3. France
      • 11.2.1.4. U.K.
      • 11.2.1.5. Spain
      • 11.2.1.6. Russia
      • 11.2.1.7. BENELUX
      • 11.2.1.8. Rest of Europe
    • 11.2.2. By Product Type
    • 11.2.3. By Age Group
    • 11.2.4. By Application
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Age Group
    • 11.3.4. By Application
  • 11.4. Key Takeaways

12. East Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. South Korea
    • 12.2.2. By Product Type
    • 12.2.3. By Age Group
    • 12.2.4. By Application
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By Age Group
    • 12.3.4. By Application
  • 12.4. Key Takeaways

13. South Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Thailand
      • 13.2.1.3. Malaysia
      • 13.2.1.4. Indonesia
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Product Type
    • 13.2.3. By Age Group
    • 13.2.4. By Application
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product Type
    • 13.3.3. By Age Group
    • 13.3.4. By Application
  • 13.4. Key Takeaways

14. Oceania Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. Australia
      • 14.2.1.2. New Zealand
    • 14.2.2. By Product Type
    • 14.2.3. By Age Group
    • 14.2.4. By Application
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product Type
    • 14.3.3. By Age Group
    • 14.3.4. By Application
  • 14.4. Key Takeaways

15. MEA Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. GCC
      • 15.2.1.2. Rest of MEA
    • 15.2.2. By Product Type
    • 15.2.3. By Age Group
    • 15.2.4. By Application
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Product Type
    • 15.3.3. By Age Group
    • 15.3.4. By Application
  • 15.4. Key Takeaways

16. Key Countries Membrane Oxygenators Market Analysis

  • 16.1. U.S.
    • 16.1.1. Pricing Analysis
    • 16.1.2. Market Share Analysis, 2024
      • 16.1.2.1. By Product Type
      • 16.1.2.2. By Age Group
      • 16.1.2.3. By Application
  • 16.2. Canada
    • 16.2.1. Pricing Analysis
    • 16.2.2. Market Share Analysis, 2024
      • 16.2.2.1. By Product Type
      • 16.2.2.2. By Age Group
      • 16.2.2.3. By Application
  • 16.3. Brazil
    • 16.3.1. Pricing Analysis
    • 16.3.2. Market Share Analysis, 2024
      • 16.3.2.1. By Product Type
      • 16.3.2.2. By Age Group
      • 16.3.2.3. By Application
  • 16.4. Mexico
    • 16.4.1. Pricing Analysis
    • 16.4.2. Market Share Analysis, 2024
      • 16.4.2.1. By Product Type
      • 16.4.2.2. By Age Group
      • 16.4.2.3. By Application
  • 16.5. Argentina
    • 16.5.1. Pricing Analysis
    • 16.5.2. Market Share Analysis, 2024
      • 16.5.2.1. By Product Type
      • 16.5.2.2. By Age Group
      • 16.5.2.3. By Application
  • 16.6. Germany
    • 16.6.1. Pricing Analysis
    • 16.6.2. Market Share Analysis, 2024
      • 16.6.2.1. By Product Type
      • 16.6.2.2. By Age Group
      • 16.6.2.3. By Application
  • 16.7. Italy
    • 16.7.1. Pricing Analysis
    • 16.7.2. Market Share Analysis, 2024
      • 16.7.2.1. By Product Type
      • 16.7.2.2. By Age Group
      • 16.7.2.3. By Application
  • 16.8. France
    • 16.8.1. Pricing Analysis
    • 16.8.2. Market Share Analysis, 2024
      • 16.8.2.1. By Product Type
      • 16.8.2.2. By Age Group
      • 16.8.2.3. By Application
  • 16.9. U.K.
    • 16.9.1. Pricing Analysis
    • 16.9.2. Market Share Analysis, 2024
      • 16.9.2.1. By Product Type
      • 16.9.2.2. By Age Group
      • 16.9.2.3. By Application
  • 16.10. Spain
    • 16.10.1. Pricing Analysis
    • 16.10.2. Market Share Analysis, 2024
      • 16.10.2.1. By Product Type
      • 16.10.2.2. By Age Group
      • 16.10.2.3. By Application
  • 16.11. Russia
    • 16.11.1. Pricing Analysis
    • 16.11.2. Market Share Analysis, 2024
      • 16.11.2.1. By Product Type
      • 16.11.2.2. By Age Group
      • 16.11.2.3. By Application
  • 16.12. BENELUX
    • 16.12.1. Pricing Analysis
    • 16.12.2. Market Share Analysis, 2024
      • 16.12.2.1. By Product Type
      • 16.12.2.2. By Age Group
      • 16.12.2.3. By Application
  • 16.13. China
    • 16.13.1. Pricing Analysis
    • 16.13.2. Market Share Analysis, 2024
      • 16.13.2.1. By Product Type
      • 16.13.2.2. By Age Group
      • 16.13.2.3. By Application
  • 16.14. Japan
    • 16.14.1. Pricing Analysis
    • 16.14.2. Market Share Analysis, 2024
      • 16.14.2.1. By Product Type
      • 16.14.2.2. By Age Group
      • 16.14.2.3. By Application
  • 16.15. South Korea
    • 16.15.1. Pricing Analysis
    • 16.15.2. Market Share Analysis, 2024
      • 16.15.2.1. By Product Type
      • 16.15.2.2. By Age Group
      • 16.15.2.3. By Application
  • 16.16. India
    • 16.16.1. Pricing Analysis
    • 16.16.2. Market Share Analysis, 2024
      • 16.16.2.1. By Product Type
      • 16.16.2.2. By Age Group
      • 16.16.2.3. By Application
  • 16.17. Thailand
    • 16.17.1. Pricing Analysis
    • 16.17.2. Market Share Analysis, 2024
      • 16.17.2.1. By Product Type
      • 16.17.2.2. By Age Group
      • 16.17.2.3. By Application
  • 16.18. Malaysia
    • 16.18.1. Pricing Analysis
    • 16.18.2. Market Share Analysis, 2024
      • 16.18.2.1. By Product Type
      • 16.18.2.2. By Age Group
      • 16.18.2.3. By Application
  • 16.19. Indonesia
    • 16.19.1. Pricing Analysis
    • 16.19.2. Market Share Analysis, 2024
      • 16.19.2.1. By Product Type
      • 16.19.2.2. By Age Group
      • 16.19.2.3. By Application
  • 16.20. Australia
    • 16.20.1. Pricing Analysis
    • 16.20.2. Market Share Analysis, 2024
      • 16.20.2.1. By Product Type
      • 16.20.2.2. By Age Group
      • 16.20.2.3. By Application
  • 16.21. New Zealand
    • 16.21.1. Pricing Analysis
    • 16.21.2. Market Share Analysis, 2024
      • 16.21.2.1. By Product Type
      • 16.21.2.2. By Age Group
      • 16.21.2.3. By Application
  • 16.22. GCC Countries
    • 16.22.1. Pricing Analysis
    • 16.22.2. Market Share Analysis, 2024
      • 16.22.2.1. By Product Type
      • 16.22.2.2. By Age Group
      • 16.22.2.3. By Application

17. Market Structure Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Market Share Analysis of Top Players
    • 17.3.1. By Regional
    • 17.3.2. By Product Type
    • 17.3.3. By Age Group
    • 17.3.4. By Application

18. Competition Analysis

  • 18.1. Competition Deep Dive
    • 18.1.1. MicroPort Scientific Corporation
      • 18.1.1.1. Overview
      • 18.1.1.2. Product Portfolio
      • 18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.1.4. Sales Footprint
      • 18.1.1.5. Strategy Overview
        • 18.1.1.5.1. Marketing Strategy
        • 18.1.1.5.2. Product Strategy
        • 18.1.1.5.3. Channel Strategy
    • 18.1.2. Nipro Medical Corporation
      • 18.1.2.1. Overview
      • 18.1.2.2. Product Portfolio
      • 18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.2.4. Sales Footprint
      • 18.1.2.5. Strategy Overview
        • 18.1.2.5.1. Marketing Strategy
        • 18.1.2.5.2. Product Strategy
        • 18.1.2.5.3. Channel Strategy
    • 18.1.3. Medtronic
      • 18.1.3.1. Overview
      • 18.1.3.2. Product Portfolio
      • 18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.3.4. Sales Footprint
      • 18.1.3.5. Strategy Overview
        • 18.1.3.5.1. Marketing Strategy
        • 18.1.3.5.2. Product Strategy
        • 18.1.3.5.3. Channel Strategy
    • 18.1.4. Fresenius SE & Co KGaA
      • 18.1.4.1. Overview
      • 18.1.4.2. Product Portfolio
      • 18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.4.4. Sales Footprint
      • 18.1.4.5. Strategy Overview
        • 18.1.4.5.1. Marketing Strategy
        • 18.1.4.5.2. Product Strategy
        • 18.1.4.5.3. Channel Strategy
    • 18.1.5. Terumo Medical Corporation
      • 18.1.5.1. Overview
      • 18.1.5.2. Product Portfolio
      • 18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.5.4. Sales Footprint
      • 18.1.5.5. Strategy Overview
        • 18.1.5.5.1. Marketing Strategy
        • 18.1.5.5.2. Product Strategy
        • 18.1.5.5.3. Channel Strategy
    • 18.1.6. Getinge AB
      • 18.1.6.1. Overview
      • 18.1.6.2. Product Portfolio
      • 18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.6.4. Sales Footprint
      • 18.1.6.5. Strategy Overview
        • 18.1.6.5.1. Marketing Strategy
        • 18.1.6.5.2. Product Strategy
        • 18.1.6.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦